Caffeic acid phenethyl ester (CAPE) has been reported to improve metabolic syndrome, inhibit basal lipolysis and activate adipose tissue remodeling via the PPARγ signaling pathway in high-fat diet-induced obese rats [112]. The gene discussed is PPARG; the disease is metabolic syndrome.